Now’s an optimal time to consider acting on our options trades. Read More
Analysis
Filter
Clear FilterHere’s a review of the major events regarding our picks and how you should act. Read More
Time to pull the trigger on Vuzix. I’m putting this augmented reality pioneer into the portfolio. Read More
Whether it’s NVIDIA’s tailwind from blockchain technology or Taiwan Semiconductor’s unwarranted downgrading from obtuse analysts, the fundamentals for our portfolio holdings remain solid. Read More
Driving the bull market is the technology sector, as exemplified by our fast-rising tech all-stars. Here’s an update. Read More
Our picks have enjoyed a phenomenal third quarter. Here, I calibrate our buy targets, mostly on the upside. Read More
As additional quarterly operating results pour in, it’s apparent that our portfolio holdings are well chosen and well-positioned for market-beating growth. Read More
New statistics and operating results show that the VR/AR industry continues to thrive. Here’s a look at the latest developments among the related stocks in our portfolio. Read More
Go ahead, pop the champagne. Our portfolio holdings racked up impressive operating results in the latest quarter. Read More
Buying the June dip in this semiconductor testing winner has paid off handsomely. Read More
Some investors are getting spooked by this tech innovator’s patent disputes with Apple, Samsung and AT&T, but we’re not overly concerned. Read More
It doesn’t matter what Tesla will or will not buy; our star performer is making all the right friends in China. Read More
The tussle over Toshiba’s flash memory unit has marked down the stock again, but the future is bright. Read More
The data storage leader holds a strong hand in its tussle over flash memory chips with Toshiba. Its stock is back and has more room to run. Read More
The latest portfolio addition delivered blowout earnings this week. But we could get another chance to buy it cheaper. Read More
We’re sitting on a growing number of big bull market winners and you should too. Embrace the boredom and the gains will follow. Read More
Several recent picks have rallied for all the right reasons, and we’re not backing away from these winners. Read More
Sell the portfolio’s star stock only if you hate money and winning. Read More
The developer of blood disinfection kits reported stronger sales and progress with U.S. and European regulators. Read More
It’s time to capitalize on Trump Disruption, and we know just how to do it. Read More